HUMMEL ALBERT F 4
4 · WATSON PHARMACEUTICALS INC · Filed May 4, 2012
Insider Transaction Report
Form 4
HUMMEL ALBERT F
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0033
2012-05-02$26.60/sh+30,000$798,000→ 157,691 total - Sale
Common Stock, par value $0.0033
2012-05-02$74.73/sh−10,679$798,042→ 147,012 total - Exercise/Conversion
Non-Qualified Options to Purchase Common Stock
2012-05-02−30,000→ 0 totalExercise: $26.60From: 2005-05-20Exp: 2012-05-20→ Common Stock, par value $0.0033 (30,000 underlying)
Footnotes (1)
- [F1]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.